BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7480678)

  • 21. Hepatic helical CT: contrast material injection protocol.
    Foley WD; Hoffmann RG; Quiroz FA; Kahn CE; Perret RS
    Radiology; 1994 Aug; 192(2):367-71. PubMed ID: 8029399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of different threshold levels and injection rates on hepatic enhancement by using bolus tracking technique in helical CT].
    Erdoğan C; Savci G
    Tani Girisim Radyol; 2003 Jun; 9(2):207-12. PubMed ID: 14661491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement and safety of iomeprol-400 and iodixanol-320 in patients undergoing abdominal multidetector CT.
    Romano L; Grazioli L; Bonomo L; Xu JR; Chen KM; Dore R; Vanzulli A; Catalano C
    Br J Radiol; 2009 Mar; 82(975):204-11. PubMed ID: 19064592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate--pharmacokinetic analysis and experimental porcine model.
    Bae KT; Heiken JP; Brink JA
    Radiology; 1998 Feb; 206(2):455-64. PubMed ID: 9457200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of pharmacokinetics to electron-beam tomography of the abdomen.
    Krause W; Gröll R; Kern R; Baumgartner C; Rienmüller R
    Acad Radiol; 1999 Aug; 6(8):487-95. PubMed ID: 10480045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of retrograde inferior vena cava or hepatic vein opacification during contrast-enhanced CT.
    Yeh BM; Kurzman P; Foster E; Qayyum A; Joe B; Coakley F
    AJR Am J Roentgenol; 2004 Nov; 183(5):1227-32. PubMed ID: 15505282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic helical CT of the abdomen: prospective comparison of pre- and postprandial contrast enhancement.
    Sheafor DH; Keogan MT; DeLong DM; Nelson RC
    Radiology; 1998 Feb; 206(2):359-63. PubMed ID: 9457186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Spiral-CT of the liver: optimizing contrast medium administration and examination technique].
    Vogl TJ; Hidajat N; Schröder RJ; Pegios W; Langer R; Neuhaus P; Felix R
    Aktuelle Radiol; 1996 Jan; 6(1):7-12. PubMed ID: 8852767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic CT enhancement. Part II. Alterations in contrast material volume and rate of injection within the same patients.
    Chambers TP; Baron RL; Lush RM
    Radiology; 1994 Nov; 193(2):518-22. PubMed ID: 7972771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast-enhanced spiral CT of the liver: effect of different amounts and injection rates of contrast material on early contrast enhancement.
    Small WC; Nelson RC; Bernardino ME; Brummer LT
    AJR Am J Roentgenol; 1994 Jul; 163(1):87-92. PubMed ID: 8010255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of parenchymal enhancement on dual-phase dynamic helical CT of the liver: how long does the hepatic arterial phase predominate?
    Frederick MG; McElaney BL; Singer A; Park KS; Paulson EK; McGee SG; Nelson RC
    AJR Am J Roentgenol; 1996 Jun; 166(6):1305-10. PubMed ID: 8633437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peak enhancement of the liver in children using power injection and helical CT.
    Ruess L; Bulas DI; Kushner DC; Silverman PM; Fearon TC
    AJR Am J Roentgenol; 1998 Mar; 170(3):677-81. PubMed ID: 9490952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two contrast materials with different iodine concentrations in enhancing the density of the the aorta, portal vein and liver at multi-detector row CT: a randomized study.
    Suzuki H; Oshima H; Shiraki N; Ikeya C; Shibamoto Y
    Eur Radiol; 2004 Nov; 14(11):2099-104. PubMed ID: 15309493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aortic and hepatic contrast medium enhancement at CT. Part II. Effect of reduced cardiac output in a porcine model.
    Bae KT; Heiken JP; Brink JA
    Radiology; 1998 Jun; 207(3):657-62. PubMed ID: 9609887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic CT enhancement. Part I. Alterations in the volume of contrast material within the same patients.
    Chambers TP; Baron RL; Lush RM
    Radiology; 1994 Nov; 193(2):513-7. PubMed ID: 7972770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helical CT of the liver: value of an early hepatic arterial phase.
    Bonaldi VM; Bret PM; Reinhold C; Atri M
    Radiology; 1995 Nov; 197(2):357-63. PubMed ID: 7480677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of rate of contrast medium injection on hepatic enhancement at CT.
    Garcia PA; Bonaldi VM; Bret PM; Liang L; Reinhold C; Atri M
    Radiology; 1996 Apr; 199(1):185-9. PubMed ID: 8633144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of optimal scan delay for multi-phase computed tomography using bolus-tracking technique in canine pancreas.
    Choi SY; Choi HJ; Lee KJ; Lee YW
    J Vet Med Sci; 2015 Sep; 77(9):1049-54. PubMed ID: 25843155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gadolinium as a CT contrast agent: assessment in a porcine model.
    Gierada DS; Bae KT
    Radiology; 1999 Mar; 210(3):829-34. PubMed ID: 10207488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aortic enhancement during abdominal CT angiography: correlation with test injections, flow rates, and patient demographics.
    Platt JF; Reige KA; Ellis JH
    AJR Am J Roentgenol; 1999 Jan; 172(1):53-6. PubMed ID: 9888738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.